Table 5.
Effect of dietary inclusion of an organic acids-based formulation (OABF) and avilamycin dietary inclusion on ileal mucosa-associated bacteria (log cells/g mucosa-associated cell pellet) of 42-day-old broilers.
Item | Total bacteria | Lactobacillus spp. | Clostridium coccoides subgroup | |
---|---|---|---|---|
Main effect | ||||
OABF 1 | No | 7.19 | 5.81 | 6.09 |
Yes | 7.09 | 5.75 | 6.07 | |
Avilamycin2 | No | 7.14 | 5.85 | 6.15 |
Yes | 7.14 | 5.72 | 6.00 | |
Treatments3 | ||||
CON | 7.07ab | 5.73 | 5.96 | |
OA | 7.22ab | 5.96 | 6.34 | |
OAAV | 6.97b | 5.54 | 5.79 | |
AV | 7.31a | 5.90 | 6.21 | |
Statistics | ||||
SEM4 | 0.106 | 0.184 | 0.233 | |
PO | 0.368 | 0.731 | 0.931 | |
PA | 0.956 | 0.485 | 0.525 | |
PO×A | 0.028 | 0.124 | 0.096 |
a, b Interaction means within the same column differ significantly (P ≤ 0.05).
No: no OABF addition; Yes: addition of 1 g OABF/kg diet.
No: no avilamycin addition; Yes: addition of 2.5 mg of avilamycin/kg diet.
Interaction means from 8 replicate pens per treatment. Treatments include: control – no additions (CON), 1 g OABF/kg diet (OA), avilamycin 2.5 mg active components/kg diet (AV) and combination of OA + AV (OAAV).
Pooled standard error of means.